Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.61 |
| ▸ | GAA | P10253 | 3/20 | 0.61 |
| ▸ | RAB9A | P51151 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.61 |
| ▸ | NQO2 | P16083 | 8/20 | 0.54 |
| ▸ | NPC1 | O15118 | 2/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | ACHE | P22303 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.48 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31391239 | 0.86 | MYC (0.63) | MAPTALDH1A1GAARAB9AKMT2A | |
| SCHEMBL16094567 | 0.83 | MAPT (0.48) | MAPTALDH1A1GAARAB9AKMT2A | |
| SCHEMBL8206153 | 0.83 | MAPT (0.48) | MAPTALDH1A1GAARAB9AKMT2A | |
| SCHEMBL29402115 | 0.83 | MAPT (0.71) | MAPTALDH1A1GAARAB9AKMT2A | |
| SCHEMBL2246928 | 0.83 | MAPT (0.71) | MAPTALDH1A1GAARAB9AKMT2A | |
| SCHEMBL29581806 | 0.83 | MAPT (0.71) | MAPTALDH1A1GAARAB9AKMT2A | |
| Phenazine SCHEMBL29356959 | 0.83 | MAPT (1.00) | MAPTALDH1A1GAARAB9AKMT2A | |
| Phenazine SCHEMBL27643128 | 0.83 | MAPT (1.00) | MAPTALDH1A1GAARAB9AKMT2A | |
| Phenazine SCHEMBL9049 | 0.83 | MAPT (1.00) | MAPTALDH1A1GAARAB9AKMT2A | |
| SCHEMBL27969901 | 0.80 | MAPT (0.60) | MAPTALDH1A1GAARAB9AKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115260203-B | Quinoxaline phenazine luminescent material and application thereof | 浙江工业大学 | 2024-06-14 | — | — | CN | claimed |
| CN-115260203-A | Quinoxalino-phenazine luminescent material and application thereof | 浙江工业大学 | 2022-11-01 | — | — | CN | claimed |
| US-6560004-B2 | Coupled electrochromic compounds with photostable dication oxidation states | GENTEX CORPORATION | 2003-05-06 | — | — | US | claimed |
| US-20020018281-A1 | Coupled electrochromic compounds with photostable dication oxidation states | THEISTE DAVID A (US) | 2002-02-14 | — | — | US | claimed |
| US-6249369-B1 | Coupled electrochromic compounds with photostable dication oxidation states | GENTEX CORPORATION | 2001-06-19 | — | — | US | claimed |
| US-5998617-A | MIXTURE OF ELECTROACTIVE MATERIALS AT PRESELECTIVE CONCENTRATION; GRAY COLOR | GENTEX CORPORATION (US) | 1999-12-07 | — | — | US | claimed |
| US-12252498-B2 | Electrochromic devices having a buffer system | GENTEX CORPORATION (US) | 2025-03-18 | — | — | US | disclosed |
| EP-4511696-A1 | ELECTROCHROMIC DEVICES HAVING A BUFFER SYSTEM | GENTEX CORPORATION (US) | 2025-02-26 | — | — | EP | disclosed |
| CN-119032318-A | Electrochromic device with buffer system | 金泰克斯公司 | 2024-11-26 | — | — | CN | disclosed |
| CN-115260203-B | Quinoxaline phenazine luminescent material and application thereof | 浙江工业大学 | 2024-06-14 | — | — | CN | disclosed |
| US-20230382938-A1 | ELECTROCHROMIC DEVICES HAVING A BUFFER SYSTEM | GENTEX CORPORATION (US) | 2023-11-30 | — | — | US | disclosed |
| WO-2023205262-A1 | ELECTROCHROMIC DEVICES HAVING A BUFFER SYSTEM | GENTEX CORPORATION (US) | 2023-10-26 | — | — | WO | disclosed |
| CN-115348996-A | Adhesive composition | 日本曹达株式会社 | 2022-11-15 | — | — | CN | disclosed |
| US-6249369-B1 | Coupled electrochromic compounds with photostable dication oxidation states | GENTEX CORPORATION | 2001-06-19 | — | — | US | disclosed |
| WO-2001040858-A1 | ELECTROACTIVE MATERIALS AND BENEFICIAL AGENTS HAVING A SOLUBLIZING MOIETY | GENTEX CORPORATION (US) | 2001-06-07 | — | — | WO | disclosed |
| US-6037471-A | FOR ELECTROCHROMIC MIRRORS FOR MOTOR VEHICLES | GENTEX CORPORATION (US) | 2000-03-14 | — | — | US | disclosed |
| US-6020987-A | Electrochromic medium capable of producing a pre-selected color | GENTEX CORPORATION (US) | 2000-02-01 | — | — | US | disclosed |
| EP-0972227-A1 | AN IMPROVED ELECTROCHROMIC MEDIUM CAPABLE OF PRODUCING A PRE-SELECTED COLOR | GENTEX CORPORATION (US) | 2000-01-19 | — | — | EP | disclosed |
| US-5998617-A | MIXTURE OF ELECTROACTIVE MATERIALS AT PRESELECTIVE CONCENTRATION; GRAY COLOR | GENTEX CORPORATION (US) | 1999-12-07 | — | — | US | disclosed |
| WO-1998044384-A1 | AN IMPROVED ELECTROCHROMIC MEDIUM CAPABLE OF PRODUCING A PRE-SELECTED COLOR | GENTEX CORPORATION (US) | 1998-10-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230382938-A1 | ELECTROCHROMIC DEVICES HAVING A BUFFER SYSTEM | HCN2, HCN1, HCN3 | MAPT 3087/4885ALDH1A1 1718/4885GAA 1756/4885 |
| US-12252498-B2 | Electrochromic devices having a buffer system | HCN2, HCN1, HCN3 | MAPT 3087/4885ALDH1A1 1718/4885GAA 1756/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.